These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 3010112)

  • 1. HTLV-III seropositivity in 1971-1972 parenteral drug abusers--a case of false positives or evidence of viral exposure?
    Moore JD; Cone EJ; Alexander SS
    N Engl J Med; 1986 May; 314(21):1387-8. PubMed ID: 3010112
    [No Abstract]   [Full Text] [Related]  

  • 2. Prevalence of antibodies to HTLV-I, -II, and -III in intravenous drug abusers from an AIDS endemic region.
    Robert-Guroff M; Weiss SH; Giron JA; Jennings AM; Ginzburg HM; Margolis IB; Blattner WA; Gallo RC
    JAMA; 1986 Jun; 255(22):3133-7. PubMed ID: 3009910
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Usefulness of the determination of anti-HTLV-III antibodies in parenteral drug addicts].
    Forteza-Rei J; Altés J; Villalonga C; Riera M
    Med Clin (Barc); 1986 Apr; 86(14):610. PubMed ID: 3014238
    [No Abstract]   [Full Text] [Related]  

  • 4. Importance of confirmatory tests after strongly positive HTLV-III screening tests.
    Martin PW; Burger DR; Caouette S; Goldstein AS; Peetoom F
    N Engl J Med; 1986 Jun; 314(24):1577. PubMed ID: 3012336
    [No Abstract]   [Full Text] [Related]  

  • 5. Heat inactivation of serum may interfere with tests for antibodies to LAV/HTLV-III.
    van Beers D; Duys M; Maes M; Biarent D; Haumont D
    J Virol Methods; 1985 Dec; 12(3-4):329. PubMed ID: 3009518
    [No Abstract]   [Full Text] [Related]  

  • 6. HIV IgM antibodies in risk groups who are seronegative on ELISA testing.
    Bedarida G; Cambiè G; D'Agostino F; Ronsivalle MG; Berto E; Grisi ME
    Lancet; 1986 Sep; 2(8506):570-1. PubMed ID: 2875298
    [No Abstract]   [Full Text] [Related]  

  • 7. Screening donated blood and plasma for HTLV-III antibody. Facing more than one crisis?
    Osterholm MT; Bowman RJ; Chopek MW; McCullough JJ; Korlath JA; Polesky HF
    N Engl J Med; 1985 May; 312(18):1185-9. PubMed ID: 2984568
    [No Abstract]   [Full Text] [Related]  

  • 8. High frequency of HTLV-III antibodies among heterosexual intravenous drug abusers in the Austrian Tyrol.
    Fuchs D; Blecha HG; Deinhardt F; Dierich MP; Goebel FD; Hengster P; Hinterhuber H; Schoenitzer D; Traill K; Wachter H
    Lancet; 1985 Jun; 1(8444):1506. PubMed ID: 2861431
    [No Abstract]   [Full Text] [Related]  

  • 9. HTLV-III antibody in intravenous drug abusers of metropolitan Barcelona, Spain.
    Tor J; Muga R; Argelagues E; Rey-Joly C; Foz M; Ribas-Mundó M
    Arch Intern Med; 1986 Apr; 146(4):805. PubMed ID: 3008680
    [No Abstract]   [Full Text] [Related]  

  • 10. HTLV-III antibody in Swiss and English intravenous drug abusers.
    Mortimer PP; Vandervelde EM; Jesson WJ; Pereira MS; Burkhardt F
    Lancet; 1985 Aug; 2(8452):449-50. PubMed ID: 2863476
    [No Abstract]   [Full Text] [Related]  

  • 11. Antibodies to AIDS-associated retrovirus (HTLV-III/LAV) in drug addicts from Vizcaya, northern Spain.
    Merino F; Esparza B; Aizpiri J; Fernandez J; de Masdelval L; Arrieta A; Velazquez M; Volsky DJ; San Cristobal E; de Izaguirre A
    AIDS Res; 1986; 2(2):133-40. PubMed ID: 3013221
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HTLV-III antibodies in drug addicts in Spain.
    Rodrigo JM; Serra MA; Aguilar E; del Olmo JA; Gimeno V; Aparisi L
    Lancet; 1985 Jul; 2(8447):156-7. PubMed ID: 2862347
    [No Abstract]   [Full Text] [Related]  

  • 13. [Prevalence of antibodies against HTLV-III in various regions in Switzerland].
    Schüpbach J; Vogt M; Bhushan R; Lüthy R; Haller O; Joller H; Ferber T; Büchner S; Schuppli R; Schädelin J
    Schweiz Med Wochenschr; 1985 Jul; 115(30):1048-54. PubMed ID: 2994208
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A stage model of HTLV-III LAV infection in intravenous drug users.
    Des Jarlais DC; Friedman SR; Spira TJ; Zolla-Pazner S; Marmor M; Holzman R; Mildvan D; Yancovitz S; Mathur-Wagh U; Garber J
    NIDA Res Monogr; 1986; 67():328-34. PubMed ID: 3018574
    [No Abstract]   [Full Text] [Related]  

  • 15. Photometric reading of anti-HTLV-III ELISA kits.
    Grunnet N; Jersild C; Georgsen J
    Lancet; 1985 Dec; 2(8467):1302. PubMed ID: 2866361
    [No Abstract]   [Full Text] [Related]  

  • 16. Transmission of HTLV-II.
    Chorba T
    JAMA; 1986 Dec; 256(22):3094. PubMed ID: 2878093
    [No Abstract]   [Full Text] [Related]  

  • 17. HTLV-III antibody among Italian drug addicts.
    Ferroni P; Geroldi D; Galli C; Zanetti AR; Cargnel A
    Lancet; 1985 Jul; 2(8445):52-3. PubMed ID: 2861509
    [No Abstract]   [Full Text] [Related]  

  • 18. The journal of infection control nursing. AIDS Q&A.
    Nurs Times; 1987 Jun 3-9; 83(22):75. PubMed ID: 3037502
    [No Abstract]   [Full Text] [Related]  

  • 19. Blood banks give HTLV-III test positive appraisal at five months.
    Marwick C
    JAMA; 1985 Oct; 254(13):1681-3. PubMed ID: 2993686
    [No Abstract]   [Full Text] [Related]  

  • 20. [Prevalence of anti-LAV/HTLV-III in prostitutes in Seville].
    Pineda JA; Leal M; García de Pesquera F; Sánchez-Quijano A; Rivera F; Lissen E
    Med Clin (Barc); 1986 Mar; 86(12):498-500. PubMed ID: 3012223
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.